New Study: Global Transdermal Drug Delivery Systems Market 2021 Size, Growth Analysis Report, Forecast to 2026

The transdermal drug delivery systems market was valued at $6,063.85 million in 2019 and is expected to reach $8,415.04 million by 2027. It is expected to grow at a CAGR of 4% from 2021 to 2027. The prevalence of chronic diseases where existing drug delivery systems, such as oral medications, have low efficacy due to primary metabolism of the liver, is leading the market.

A full report of Transdermal Drug Delivery Systems Market available at https://www.orionmarketreports.com/transdermal-drug-delivery-systems-market/53494/

Key Market Players

The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

Transdermal Drug Delivery Systems Market Segmentations

By Type of Delivery System

Passive

• Matrix System
• Reservoir System

Active

• Structure Based
• Electrical Based
• Others

By Application

• Analgesics
• Hormone Replacement Therapy
• Cardiovascular Disorders
• Motion Sickness
• Smoking Cessation
• Others

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

The report covers the following objectives:

• Proliferation and maturation of trade in the Transdermal Drug Delivery Systems Market.
• The market share of the Transdermal Drug Delivery Systems Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the Transdermal Drug Delivery Systems Market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Transdermal Drug Delivery Systems Market.

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Key Questions Answered by Transdermal Drug Delivery Systems Market Report

• What was the Transdermal Drug Delivery Systems Market in 2020 and 2021; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Transdermal Drug Delivery Systems Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2018? How are these segments are expected to grow during the forecast period (2021-2027)?
• Which manufacturer/vendor/players in the Transdermal Drug Delivery Systems Market was the market leader in 2018?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.